Literature DB >> 33087212

COVID-19 Result Follow-Up Process in the Pediatric Emergency Department Setting.

Shaina Newman1, Joelle Simpson1, Ashley Perritt1, Sephora Morrison1, Deena Berkowitz1, Kathleen Brown1, Tress Goodwin1.   

Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic upended the world. As emergency departments and hospitals across the nation and world braced themselves for the surge of this new disease, the emergency department (ED) at Children's National Hospital (CNH) quickly created a process to address surges in patient visits and follow-ups for coronavirus testing. Within 2 wk of the first reported pediatric patient diagnosed with COVID-19 in the Washington, DC, metropolitan area, CNH ED implemented a new comprehensive follow-up process. This article describes the novel process that ensured timely notification of testing results, enabled patients to speak remotely with ED providers, increased patient and staff safety by reducing unnecessary exposures, and suggested a good patient experience. With over 1900 patients discharged pending their COVID-19 results, the program is successful. We anticipate expansion into antibody testing and notification as the pandemic progresses.

Entities:  

Keywords:  COVID-19; delivery of health care; disease outbreaks; emergency medicine; emergency preparedness

Year:  2020        PMID: 33087212     DOI: 10.1017/dmp.2020.403

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  2 in total

1.  To pollute or not to pollute? Decreasing the ecological footprint of pediatrics in the COVID-19 era.

Authors:  Yakup Gozderesi; Christos Tsagkaris; Anna Eleftheriades; Panagiota Pervanidou
Journal:  J Clim Chang Health       Date:  2022-05-18

2.  Coronavirus Disease 2019 in the Emergency Department: Establishing an Interprofessional Incident Command System.

Authors:  Timothy Holtzclaw; Shaina Derstine Newman; Matthew Dwyer; Joelle Simpson; Tress Goodwin
Journal:  J Emerg Nurs       Date:  2022-07       Impact factor: 2.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.